Silexion Therapeutics Corp Ordinary Shares (SLXN) is a publicly traded Healthcare sector company. As of July 22, 2026, SLXN trades at $2.57 with a market cap of $2.75M and a P/E ratio of 0.10. SLXN moved -2.70% today. Year to date, SLXN is -86.93%; over the trailing twelve months it is -97.97%. Its 52-week range spans $2.31 to $634.50. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces SLXN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SLXN shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.57 |
| Market Cap | $2.75M |
| P/E Ratio | 0.10 |
| EPS | $26.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $634.50 |
| 52-Week Low | $2.31 |
| Volume | 17.63K |
| Avg Volume | 0 |
| Revenue (TTM) | $28.00K |
| Net Income | $-16.52M |
| Gross Margin | 0.00% |
1 analysts cover SLXN: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.